Business Description
cbdMD Inc
NAICS : 325412
SIC : 2834
Share Class Description:
YCBDPA.PFD: 8% PRF PERPETUAL USD 10 Ser ATotal Employee Number:
42Description
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.36 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.43 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -17.75 | |||||
Beneish M-Score | -1.93 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -71.8 | |||||
3-Year EBITDA Growth Rate | 89.8 | |||||
3-Year EPS without NRI Growth Rate | 79.5 | |||||
3-Year FCF Growth Rate | 83.7 | |||||
3-Year Book Growth Rate | -83.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-1 Month Momentum % | 15.18 | |||||
6-1 Month Momentum % | 84.36 | |||||
12-1 Month Momentum % | 76.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.82 | |||||
Quick Ratio | 1.71 | |||||
Cash Ratio | 0.89 | |||||
Days Inventory | 130.33 | |||||
Days Sales Outstanding | 21.01 | |||||
Days Payable | 53.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -275.1 | |||||
Shareholder Yield % | 18.92 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.38 | |||||
Operating Margin % | -13.4 | |||||
Net Margin % | -13.29 | |||||
EBITDA Margin % | -4.79 | |||||
ROE % | -41.12 | |||||
ROA % | -24.02 | |||||
ROIC % | -40.53 | |||||
3-Year ROIIC % | -66.66 | |||||
ROC (Joel Greenblatt) % | -89.21 | |||||
ROCE % | -40.7 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.28 | |||||
PB Ratio | 0.77 | |||||
EV-to-EBIT | -1.84 | |||||
EV-to-EBITDA | -5.14 | |||||
EV-to-Revenue | 0.25 | |||||
EV-to-FCF | -1.85 | |||||
Earnings Yield (Greenblatt) % | -54.35 | |||||
FCF Yield % | -37.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:YCBDPA.PFD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
cbdMD Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.13 | ||
| 3-Year Sortino Ratio | -0.18 | ||
| Volatility % | 88.95 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | 76.71 | ||
| 52-Week Range ($) | 0.31 - 1.68 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
cbdMD Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
cbdMD Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-12-18 | In 168 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-14 16:20 | In 43 days | ||
| Third quarter earnings results for 2026 | 2026-08-14 | In 42 days | ||
| Second quarter earnings conference call for 2026 | 2026-05-14 16:20 | 1.65 (-1.20%) | ||
| Second quarter earnings results for 2026 | 2026-05-14 | 1.65 (-1.20%) | ||
| General meeting for 2026 | 2026-03-30 11:00 | 1.65 (-1.20%) | ||
| First quarter earnings conference call for 2026 | 2026-02-17 16:20 | 1.65 (-1.20%) | ||
| First quarter earnings results for 2026 | 2026-02-17 | 1.65 (-1.20%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-12-19 16:20 | 1.65 (-1.20%) | ||
| Annual report for 2025 | 2025-12-19 | 1.65 (-1.20%) |
Show
Entries
cbdMD Inc Frequently Asked Questions
What is cbdMD Inc(YCBDPA.PFD)'s stock price today?
The current price of YCBDPA.PFD is $1.54. The 52 week high of YCBDPA.PFD is $1.68 and 52 week low is $0.31.
When is next earnings date of cbdMD Inc(YCBDPA.PFD)?
The next earnings date of cbdMD Inc(YCBDPA.PFD) is 2026-08-14 Est..
Does cbdMD Inc(YCBDPA.PFD) pay dividends? If so, how much?
cbdMD Inc(YCBDPA.PFD) does not pay dividend.
Guru Commentaries on AMEX:YCBDPA.PFD
No articles.
Press Release
Articles on cbdMD Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers